3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uveal Melanoma
1
Retinal Diseases
1
Melanoma
1
Macular Degeneration
1
Choroid Diseases
1
Interventions
Nivolumab
2
Ipilimumab
2
salicylhydroxamic acid
1
pembrolizumab
1
Triamcinolone Acetonide
1
Ranibizumab
1
Dacarbazine
1
Crizotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Uveal Melanoma
×
Ranibizumab
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled